Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (CDC-RFA-PS21-2103)

Print
Related Pages

This website is designed to:

  1. Support the application process for health departments applying for Notice of Funding Opportunity (NOFO) PS21-2103; and
  2. Provide a forum for the dissemination of important information to future PS21-2103 funded grantees.

PS21-2103 Notice of Funding Opportunity

Executive Summary

The US Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year 2021 funds for a Notice of Funding Opportunity (NOFO) to support integrated viral hepatitis surveillance and prevention programs in states and large cities in the United States. This cooperative agreement will award up to $341,020,000 over five (5) years to approximately 58 recipients under Components 1 and 2, and up to 10 recipients under Component 3. This program will support core viral hepatitis outbreak response, surveillance, and prevention activities (Components 1 and 2, required), and special projects for the prevention, diagnosis, and treatment related to the infectious disease consequences of drug use (Component 3, optional). The Infectious Disease and the Opioid Crisis initiative supports multiple components of NOFO PS21-2103.

A full list of these activities, including those that are optional or contingent on funding, can be found at www.grants.gov/web/grants/search-grants.html?keywords=CDC-RFA-PS21-2103.

Purpose

Priorities for this cooperative agreement are to improve surveillance for viral hepatitis in states and large cities, including outbreak detection, investigation and control; facilitate state and large city viral hepatitis elimination planning; and increase access to hepatitis B and C testing, and prevention and treatment services (e.g., vaccination and treatment services provided in high-impact settings, such as hospital emergency departments and syringe services programs (SSPs), and among high-burden populations). An additional optional component funds comprehensive, outcome-focused approaches to preventing infections associated with injection drug use, reducing overdose deaths, and linking people to substance use disorder treatment.

Eligibility Criteria

This NOFO provides full and open competition and the following entities are eligible: all state governments or their bona fide agents (including the District of Columbia), county governments or their bona fide agents, city or township governments, and special district governments who have the responsibility, authority, and ability to enforce laws, rules, or regulations pertaining to collecting and reporting of viral hepatitis surveillance data and those that have coordinated jurisdictional-wide authority for viral hepatitis strategic planning for prevention and control activities at the state and local levels.

NOFO Frequently Asked Questions (FAQs)

Answers to questions about CDC-RFA-PS21-2103
See NOFO FAQs

Pre-Application Technical Assistance Activities and Resources

Informational Conference Calls

The Pre-Application Technical Assistance webinars will provide potential applicants the opportunity to ask CDC representatives specific questions related to the NOFO.

Call # 1: September 15, 2020 at 1:00 PM (Eastern Time) – Slides [PDF – 334 KB]

Call # 2: October 14, 2020 at 1:00 PM (Eastern Time) – Slides [PDF – 536 KB]

General Information

Where to Find and Access Notice of Funding Opportunity (NOFO) PS21-2103: Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments

To access the application package for PS21-2103: Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments

  1. Go to: www.grants.gov
  2. Select: “Applicants” from the top menu
  3. Select: “Apply for Grants”
  4. Select: “Search for Opportunity Package”
  5. In the “Funding Opportunity Number” box, type: CDC-RFA-PS21-2103, click “search”

This website will be updated regularly with new information.

Eligible Applicants for PS21-2103

Please refer to NOFO Eligibility Information for a list of eligible entities and for more information. This NOFO provides full and open competition and the following entities are eligible:

  • All state governments or their bona fide agents (including the District of Columbia), county governments or their bona fide agents, city or township governments, and special district governments who have the responsibility, authority, and ability to enforce laws, rules, or regulations pertaining to collecting and reporting of viral hepatitis surveillance data and those that have coordinated jurisdictional-wide authority for viral hepatitis strategic planning for prevention and control activities at the state and local levels.

Key Dates and Award Information

Publication: August 25, 2020

Letter of Intent Due (encouraged, not required): September 30, 2020

Applications Due: December 1, 2020 at 11:59 pm U.S. Eastern Time

Estimated Project Start Date: May 1, 2021

 

Approximate Period of Performance Length: Five (5) years

 

Approximate Number of Awards to Be Made

Component 1 Surveillance: 58

Component 2 Prevention: 58

Component 3 Special Projects: up to 10

 

Approximate Total Period of Performance Funding: Up to $341,020,000

 

Approximate Year-One Awards

These amounts are subject to availability of funds.

Component 1 Surveillance: $200,000

Component 2 Prevention: $115,000

Component 3 Special Projects: $300,000

Attachments and Important Resources

Attachments

The attachments below are in Adobe Acrobat (PDF) format. Please go to www.grants.gov to download the application you will need to complete.

The attachments below are in Word format and may be downloaded and edited.

Important Resources

Contacts

For questions, please send an email to dvh_foa@cdc.gov. A response to your question will be provided within 48 business hours.